142 related articles for article (PubMed ID: 9952039)
1. Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor.
Scearce-Levie K; Viswanathan SS; Hen R
Psychopharmacology (Berl); 1999 Jan; 141(2):154-61. PubMed ID: 9952039
[TBL] [Abstract][Full Text] [Related]
2. Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine.
Compan V; Scearce-Levie K; Crosson C; Daszuta A; Hen R
Eur J Neurosci; 2003 Jul; 18(2):383-90. PubMed ID: 12887420
[TBL] [Abstract][Full Text] [Related]
3. Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice.
Dulawa SC; Scearce-Levie KA; Hen R; Geyer MA
Psychopharmacology (Berl); 2000 Apr; 149(3):306-12. PubMed ID: 10823412
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
McCreary AC; Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
[TBL] [Abstract][Full Text] [Related]
5. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Rempel NL; Callaway CW; Geyer MA
Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
[TBL] [Abstract][Full Text] [Related]
6. 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.
Conductier G; Crosson C; Hen R; Bockaert J; Compan V
Neuropsychopharmacology; 2005 Jun; 30(6):1056-63. PubMed ID: 15668722
[TBL] [Abstract][Full Text] [Related]
7. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
Mlinar B; Corradetti R
Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
[TBL] [Abstract][Full Text] [Related]
8. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
Callaway CW; Rempel N; Peng RY; Geyer MA
Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
[TBL] [Abstract][Full Text] [Related]
11. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
Fletcher PJ; Korth KM; Robinson SR; Baker GB
Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
[TBL] [Abstract][Full Text] [Related]
12. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
[TBL] [Abstract][Full Text] [Related]
13. MDMA modulates 5-HT
Fonseca DA; Teixeira C; Carvalho F; Fernandes E; Antunes PE; Antunes MJ; Cotrim MD
Toxicol In Vitro; 2019 Mar; 55():15-17. PubMed ID: 30448555
[TBL] [Abstract][Full Text] [Related]
14. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA
Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902
[TBL] [Abstract][Full Text] [Related]
15. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors.
Bankson MG; Cunningham KA
Neuropsychopharmacology; 2002 Jan; 26(1):40-52. PubMed ID: 11751031
[TBL] [Abstract][Full Text] [Related]
17. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
[TBL] [Abstract][Full Text] [Related]
18. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor.
Amato JL; Bankson MG; Yamamoto BK
Neuropsychopharmacology; 2007 Apr; 32(4):946-54. PubMed ID: 16885935
[TBL] [Abstract][Full Text] [Related]
19. (+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain.
Sexton TJ; McEvoy C; Neumaier JF
Mol Psychiatry; 1999 Nov; 4(6):572-9. PubMed ID: 10578240
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
